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adult-centered care; however, little is known about outcome measurements within this period.
We assessed the trend in adolescent HIV viral loads (VLs) in a community with a high HIV prev-
alence, allowing physicians to better recognize the challenges of transitioning adolescents
with HIV to adult care.
Patients and methods: All HIV RNA VLs from the Molecular Virology Lab at University Hospital in
Newark, New Jersey, from 2007 to 2010 were obtained. Patients were divided into pediatric
(<13 years of age), adolescent (13e25 years of age), and adult (>25 years of age) age groups.
Univariate and multivariate analyses assessed characteristics of patients by age and gender.
Results: A minimum of 40 pediatric, 178 adolescent, and 1335 adult patients were identified
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104 K. Wong et al.to pediatric patients (P < .02). In 3 of the 4 years, there was a statistically significant increase
in the rate of male adolescents reaching undetectable VLs compared to female adolescents.
The average VL by age demonstrated increasing VLs from age 12 through age 24, while the per-
centage of patients reaching undetectable VLs peaked at 80% at age 8 and declined through
age 24.
Conclusion: Successful transitional care programs should focus on pediatric needs to address
the noticeable decrease in virologic control beginning at 8 years of age and the decreased rate
of virologic suppression in females, creating concern for potential gender inequalities and
increased risk of vertical transmission.
Copyright ª 2016, King Faisal Specialist Hospital & Research Centre (General Organization),
Saudi Arabia. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Human immunodeficiency virus (HIV) in the adolescent
community is an increasing concern. Globally, there are
more than 2 million adolescents living with HIV [1]. Ado-
lescents often engage in high-risk sexual behavior, and in-
dividuals aged 15e19 have the highest reported rates of
sexually transmitted infections (STIs). Among high school
students in 2013, 46.8% have had sexual intercourse, 34%
were currently sexually active, and 48.9% of the currently
sexually active students did not use a condom the last time
they had sexual intercourse. Nationwide, while 85.3% of
students had been taught about acquired immune defi-
ciency syndrome (AIDS) or HIV infection in school, only
12.9% of students had ever been tested for HIV [2]. Centers
for Disease Control and Prevention (CDC) estimates the
9961 youth aged 13e24 years who were diagnosed with HIV
infections in 2013 represents 21% of the total diagnoses that
year. Around the same time, there were an estimated
62,400 youth living with HIV infection, with over half un-
diagnosed [3]. In sub-Saharan Africa, only 10% of young men
and 15% of young women aged 15e24 were aware of their
HIV status. The World Health Organization (WHO) estimates
that adolescent deaths from HIV are rising, which is
assumed to be from the lack of support and care that they
receive after childhood [1].
During this time, adolescents are facing challenges with
their own physical changes, brain development, and social
milestones. This period of transition significantly impacts
an adolescent’s ability to take ownership of their health
and successfully enter adult-centered care. In the 2013 CDC
HIV Surveillance Report, the lowest percentage of HIV pa-
tients to establish linkage of care by age group was persons
aged 13e24 years (73.4%) and the lowest percentage to be
retained in HIV medical care was persons aged 25e34 years
(46.7%) [4]. While many papers and medical organizations
recognize the importance of capturing this patient popu-
lation and preparing them for adulthood, very little has
been published regarding outcome measurements of
chronic diseases within this phase of adolescent transition.
Several programs are being developed to address this very
fragile period for young adult health, but understanding the
current outcomes in chronic disease during adolescence is
necessary for understanding the effectiveness of any tran-
sitional care program.By reviewing the HIV Viral Load (VL) data from University
Hospital in Newark, New Jersey, we assessed the trends in
adolescent HIV VLs and virologic control in an urban com-
munity with a high HIV prevalence. Knowledge of these
trends will allow physicians around the world to better
recognize the challenges of transitioning young adults with
HIV to adult-centered care and identify areas to target in
the development of appropriate transitional care programs.
2. Patients and methods
All HIV RNA VLs from the Molecular Virology Laboratory at
the University Hospital in Newark, New Jersey, from 2007 to
2010 were obtained. The study received expedited review
and approval by the Rutgers New Jersey Medical School
Institutional Review Board. Patients were divided into pe-
diatric (age <13 years), adolescent (age 13e25 years), and
adult (age >25 years) groups, all of whom were receiving
treatment at University Hospital’s HIV clinic. The clinic is
located in the Francois-Xavier Bagnoud Center and is fun-
ded in part by the Ryan White Grant Program. Through
social services, the clinic provides access to medication
assistance programs, housing programs, and mental
healthcare to all patients at point-of-care. Clinic staff
consists of two board-certified pediatric infectious diseases
physicians, two nurses, one advanced practice nurse, one
psychologist, and two social workers. Patients are typically
scheduled for 3-month follow-up visits; however, those
patients requiring more intense therapy are given more
frequent appointments. Most patients were retained in the
clinic and were not transitioned out. Over 95% of pediatric
patients were infected prenatally and many have grown up
attending the clinic. During the time period of the study, all
were offered highly active antiretroviral therapy (HAART)
with the majority receiving protease inhibitors. Some pa-
tients were receiving complex multi-tablet regimes due to
multiple past virologic failures with 3-class resistance.
The mean viral load was calculated as the average of
each individual’s viral load tests over a calendar year. Un-
detectable viral loads were assigned a value of half the
lower limit of detection, and high viral loads were assigned
the maximum limit of detection. Undetectable viral loads
were defined as <400 copies/mL, which was the most
frequent lower limit of detection used in 2001e2008. Pa-
tients were considered undetectable if they averaged an
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and multivariate analyses were performed to assess char-
acteristics of patients by age and gender.
3. Results
A minimum of 40 pediatric, 178 adolescent, and 1335 adult
patients were identified per year. There were no statisti-
cally significant differences in the mean ages of the three
groups over the four-year time period.
Males comprised 37e47% of the pediatric patients,
48e57% of the adolescent patients, and 54e57% of the
adults. Over 95% of the clinic’s HIV patients were prenatally
infected, and over 90% were actively accepting HAART.
Based on October 2010 performance measures, 75% of
patients had two clinic appointments at least 3 months
apart, 66% of patients had no less than two CD4 count
measurements, 95% of patients with CD4 counts <200
received PCP prophylaxis, 91% of patients with AIDS
received HAART, 67% received syphilis screening, and 81%
received tuberculosis screening. Lower performance rates
were recorded for cervical cancer screening in only 23% of
eligible patients. Performance data did not include age and
therefore could not be categorized into age cohorts.
The average viral loads from 2007 to 2010 were lowest
for pediatric patients, next lowest for adolescents, and
highest for adults (Table 1). This demonstrated a statisti-
cally significant increase in the mean viral load in adoles-
cents when compared to pediatric patients (42% increase,
P < .02) and in adults when compared to adolescents (195%
increase, P < .0002). The pediatric population had the
highest percentage of patients reaching undetectable VLs
(58e72.6%). The adolescent group (34.9e54.5%) and the
adult group (42.5e52.7%) were not significantly different
over the four years (Fig. 1).
In 3 of the 4 years, there was a statistically significant
increase in the percentage of male adolescents reaching
undetectable VL compared with female adolescents
(Fig. 2). Of note, 2009 was the only year in which the mean
viral load in females was lower than that of the males.
Reviewing average VL by age demonstrates an increasing
VL from age 12 through age 24, while the percentage of
patients reaching undetectable VL peaks at 80% at age 8
and begins trending down through age 24 (Fig. 3).
4. Discussion
Data from University Hospital showed evidence of wors-
ening virologic control by age group. Over the four years
analyzed, the average viral load of pediatric patients was
lower than that of the adolescent population, which in turn
was lower than that of the adult population. Within theTable 1 Average viral load by year and age group.
2007 2008 2009 2010
Pediatric 5357 7532 1885 12,248
Adolescent 37,683 27,117 10,836 17,404
Adult 57,120 53,252 36,580 51,344declining trend, the pediatric population had a significantly
higher rate of patients averaging undetectable VLs
compared with the adolescent and adult populations. The
latter populations were not significantly different with
regards to percentage of patients with undetectable VLs in
comparison to each other. In a study by Ellen et al, almost
30% of youth with HIV in 14 cities were found to have
significantly high VLs, associated with high rates of trans-
mission [5]. This troubling trend highlights the potential
challenges during adolescence that make treating and
preventing disease more difficult. Agwu et al found a
similar trend in patients with perinatally acquired HIV in
clinics across the United States e older age, black race, and
Hispanic ethnicity were associated with increased risk of
advanced immunosuppression and detectable viremia [6].
During adolescence, patients are undergoing puberty,
learning how to be autonomous young adults, and feeling
challenged by increasing responsibilities with more com-
plex external pressures [7]. While easily influenced by their
environment, peers, and mentors, these young adults are
developing behavioral foundations that will last their life
time. These foundations subsequently impact their ability
to independently manage their own health, including safer-
sex practices, disease recognition, medication compliance,
and prioritizing care.
When breaking this down further and examining mean VL
by age from birth to 25 years of age, there is notable evi-
dence of worsening virologic control and decreasing per-
centage of patients averaging undetectable VLs. The
decrease in adolescent patients reaching undetectable viral
load levels coincides with the average age of first sexual
activity and could be related to the high rates of new HIV
infections in this age group. Without proper counseling and
care, these young adults are at significant risk of acquiring
and perpetuating the spread of HIV. Additionally, given the
challenges of an inner city environment, these patients
must tackle their health concerns with limited resources
and assistance. Yet another barrier to adolescents with HIV
is its unique burden of stigma, relationship to poverty,
infection rates within families, and its prevalence within
ethnic minorities [8]. As Andiman states, “Stigma intersects
with nearly every other factor and, as experienced in social
networks, leads many youth to mistrust individuals outside
of their closest social circles, sometimes including their
[healthcare providers].” Especially in the adolescent period
when self-perception and development of self-confidence
is of high priority, having to confront and carry a stigma
during this period can lead to self-doubt and conflict:
“when adolescents fail to know or share their HIV status,
they cannot become autonomous.” [7].
Given these concerns, many programs and associations
urge the creation of multifaceted transitional care initia-
tives and specifically target the transition of an adolescent
in their early 20s. However, based on the virologic results in
this urban population, declining virologic control was noted
as young as 8 years of age. This would suggest that transi-
tional care programs should be initiated at a much younger
age and not necessarily focus on just the transfer of clinical
care, but it should focus more on the psychosocial chal-
lenges of adolescence and young adulthood. Within the
clinic studied, all patients are assessed annually for social
work and mental health needs, have access to psychosocial
Figure 1 Percent of patients reaching undetectable and average viral load by age grouping.
Figure 2 Percent of adolescent patients reaching undetectable and average viral load by gender.
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Despite extensive social and mental health services, the
decline in undetectable VLs in the adolescent population
suggests identifying more specific adolescent needs. In a
review of the Adolescent Trials Network for HIV/AIDS In-
terventions, researchers were surveyed on various aspects
of their transitional care programs. Several clinics stated
that transitions to adult care should occur between 22 and
24 years of age; however, discussions about when tran-
sitioning should begin was variable from as early as age 16
to as late as age 24. There were also discrepancies between
how a “successful transition” was measured e “informants
. were unable to accurately report an outcome” [9]. Some
barriers to monitoring outcome included the lack of
tracking mechanisms, while more anecdotal measures of
success included emotional maturity, functional indepen-
dence, available support systems, and stable health, and
housing benefits [9]. Given the young age at which declinesin virologic control was noted, these data would suggest a
transitional care program starting at the age of 8 years and
likely aimed at barriers seen in young adolescence and not
just late adolescence.
The significant decline in virologic control by age
observed in this study would also suggest that further in-
vestigations are needed to correlate adolescent percep-
tions of healthcare independence and virologic control.
While virologic control over time has largely been affected
by new advancements in antiretroviral therapy (ART),
medication adherence, and understanding barriers to this
remains tantamount to the success of any program. In a
study looking at self-reported HIV-medication adherence of
12e19-year olds, only 28.3% of patients had taken all of
their medications in the previous month, citing changes in
one’s day-to-day routine and forgetting to take medications
as the most common barriers [10]. Another study performed
at the National Institutes of Health (NIH) and National
Figure 3 Percent of pediatric and adolescent patients reaching undetectable viral load and mean viral load by age.
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readiness over a 6-month period within a closing clinical
research program. Demographics as well as CD4 cell count
and HIV-1 RNA levels were measured 6 months apart in
addition to completion of an anxiety scale and readiness
questionnaire. After barriers to transition were addressed
by the medical provider and social worker, the results
showed no significant difference in CD4 cell counts and HIV-
1 RNA levels, but there was a significant reduction in anx-
iety and increased confidence in their home community
physician, social worker, and knowledge of disease and
medications [11]. These studies suggest that adolescent
education regarding their medications, side effects, and
general care is key in developing a successful program in
medication adherence and understanding, however, it may
not result in better HIV outcomes. An early review of the
Transition Readiness Assessment created by the national
“Got Transition” program and given to adolescents in the
pediatric subspecialty clinics at University Hospital showed
good adolescent understanding of disease, emergencies,
and medications, but it showed poor understanding of
general healthcare navigation. Even in early adolescence,
however, virologic data from University Hospital indicates
that more longitudinal studies are needed to objectively
measure these transitional outcomes and correlate suc-
cessful education with virologic control.
Also concerning is that in 3 of the 4 years examined, the
viral load in adolescent females and the number of female
patients averaging undetectable VLs demonstrated wors-
ening virologic control than that of their male counterparts.
Additionally, based on the 2010 performance rates in the
clinic, only 23% of adolescent females received a cervical
cancer screening. In the 2009e2013 CDC data, rates of
infection for female adults and adolescents actually
decreased [12]; however, based on the above findings, one
can question if the healthcare system within this area is
able to deliver optimal care to females versus males. The
Enhancing Communication to Improve HIV Outcomes
(ECHO) study revealed that HIV providers had more nega-
tive perceptions of female personality characteristics than
male and felt more frustrated with female patients thanmale. Women were also shown to be less educated or un-
employed and more likely to report medication non-
adherence and depressive symptoms [13]. In New Jersey,
women had an HIV infection rate of 14.2 per 100,000 per-
sons, compared with 9.3 in New York and 5.6 in Connecticut
[14]. Adolescent girls and young women (15e24 years) are
twice as likely to be at risk of HIV infection compared to
boys and young men in the same age group worldwide [15].
Given this observed inequality, it is possible that transi-
tional care programs aimed at treating this population may
need to factor in gender inequalities psychologically, so-
cially, or otherwise.
It is also important for women to recognize that het-
erosexual contact accounted for 25% of all diagnosed HIV
infections in the United States and 86% of those infections
in adolescent and young adult women with HIV, and peri-
natally acquired infections accounted for an estimated 107
new infections in 2013 [14,15]. Globally, HIV/AIDS is the
leading cause of death among women aged 15e44 years
[15]. While maternally acquired HIV has been dramatically
reduced through the use of aggressive screening and
treatment, scattered cases remain. University Hospital had
at least one maternally acquired case of HIV in each year of
this data set. Subsequently, with poor virologic control,
females of child-bearing age in this study could represent a
future increase in maternally acquired HIV cases in Newark.
These data looked at viral load analysis performed in one
lab at one urban university hospital during a four-year span
and, consequently, is confounded by small sample sizes,
particularly in the first few years of life. The population is
also heterogeneous in terms of treatment, mode of acquisi-
tion, and stage of disease. While the majority of pediatric
and adolescent patients in our study have prenatally ac-
quired HIV, wewere unable to separate out the small number
of behaviorally acquired patientswhomayhave different risk
factors and behavioral patterns. Thus, a more in-depth study
looking at the means of transmission should follow. Other
demographic informationwould also be helpful in obtaining a
closer look at the gender differences, as well as rates of
medication compliance, clinic follow-up patterns, psycho-
social barriers to care, and adolescent-perceived attitudes
108 K. Wong et al.and knowledge of HIV and disease management. The recent
addition of the Transition Readiness Assessment to adoles-
cent care will reveal self-perceived adolescent understand-
ing of disease and healthcaremanagement. Extensive review
of these assessments and other programs in adolescent care
is required to further isolate barriers to optimal treatment.
Additionally, we do not account for the increase in effica-
cious HIV medications and treatment strategies during the
time period of this study.
5. Conclusion
Pediatric patients develop a noticeable decrease in viro-
logic control as they enter their adolescent years, which
coincides with the onset of high-risk sexual activity. This
increased viral load in infected patients puts others at
higher risk and may contribute to adolescents having the
fastest growing rate of new HIV infections. The decreased
rate of virologic suppression in females of child-bearing age
is also concerning as it presents an increased risk of vertical
transmission. The development of adolescent HIV clinics,
with dedicated services and transitional care programs
focused on the unique needs of this population early in
their adolescence, is one potential method of improving
virologic control in this high-risk group.Acknowledgments
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